MEGA SALE - UP TO 50% OFF! BLACK FRIDAY

Science and research

Nature, nurture and chronic pain: what the research shows

November 01, 2026 · 18 min read

A narrative evidence review by The Recovapro Research Team. Educational content, not medical advice. November 2026.

The research in four answers

Abstract

Chronic pain is common: an influential 2016 systematic review estimated that it affects roughly 43.5% of UK adults, though estimates depend on how chronic pain is defined and measured, and low back pain is the single leading cause of disability in 160 countries. Why some people develop persistent pain is not answered by biology alone. This paper maps what published research says about nature (what we inherit) and nurture (the lives and environments we live in), with particular attention to the modern environment: desk work, screens, stress, sleep, housing and place. The honest summary: in one large twin study, genetic factors were estimated to account for roughly a third of the population variation in chronic pain occurrence, a population-level figure that says nothing about any individual; lifestyle, work organisation, psychological and social factors show real but mostly modest associations; and the direct evidence for changing pain by changing surroundings is promising in places and thin in others. We describe what is established, what is not, and where the gaps are. We also explain, with our commercial interest declared, why a recovery-technology company is publishing this at all.

1. What is chronic pain, and why does it vary between people?

Recovapro is a British company that sells recovery hardware and is building pain-intelligence technology. We have a commercial interest in pain, and this paper should be read with that in mind. We are publishing it because our product thesis rests on a claim that should be tested in public: that pain is personal, shaped by the interaction of a person's body with their environment and history, and that understanding that interaction may prove more useful than selling one more generic fix.

The question this paper asks is simple: what does existing research actually say about how the modern environment influences pain, and what does it say about managing it? We were particularly interested in the changes most people feel in their own lives: more sitting, more screens, more ordering in, less movement, and an ageing population.

First, some honesty about terms, because this paper discusses several kinds of pain and they are not interchangeable. Pain is a personal experience and is not identical to tissue damage: most low back pain is classified as non-specific, meaning that an underlying specific pathological cause is not identified through routine clinical assessment [32]. That does not mean the pain is imaginary, or that biological and structural factors are irrelevant. Acute pain and chronic pain (usually defined as pain lasting or recurring for more than three months) are different clinical contexts. Within chronic pain, clinicians distinguish chronic primary pain, where pain itself is the main problem, from chronic secondary pain linked to an identifiable condition; the two can overlap. And pain intensity, pain-related disability and simply having pain are different outcomes. Findings about one kind of pain do not automatically transfer to another, so where a study concerns a specific condition, we say so.

A note on causation runs through everything that follows. Three statements that sound similar need very different evidence: poor sleep is associated with later pain (an observational finding); poor sleep contributes to causing pain (a causal claim); and improving sleep will reduce a particular person's pain (an intervention claim). This paper tries to keep those levels separate, and to say which level each piece of evidence can support.

2. How this evidence review was conducted

This is a narrative evidence review: an initial evidence map, not a systematic review. It draws on a literature map completed on 1 October 2026, searching academic indexes, journals, guideline bodies (NICE, WHO, Cochrane) and official statistics (HSE, ONS), with sources checked and the article assembled by 16 October 2026. We prioritised systematic reviews, meta-analyses, guidelines and official statistics. Each item was checked against the source itself, in full text where openly available and otherwise at abstract, summary or guideline-page level; no formal risk-of-bias appraisal of full papers was performed. No database-specific search strings or formal inclusion protocol were used, so this map may miss relevant work. Where we did not find something, that means "not found in this initial search", not "does not exist".

Because the review was assembled by a company with a thesis it would like to be true, we took three precautions against confirmation bias. First, an earlier draft went through a critical editorial review (30 October 2026), an editorial critique rather than independent scientific peer review, which scored it 6/10 and identified a genuine conceptual error in how we had used a heritability estimate; that error is corrected here. Second, between 30 October and 1 November 2026 we re-checked every one of the 34 cited sources against the source itself, and corrected or qualified the two claims that did not survive that check. Third, where the evidence points against a convenient narrative, including our own, we have kept it in and said so.

To help readers weigh findings, each evidence section ends with an editorial evidence summary using four labels. "Better established" means supported by relevant, reasonably consistent evidence. "Suggestive" means evidence exists but important uncertainty remains. "Limited" means evidence is sparse, indirect or methodologically weak. "Not established" means this review found no adequate answer. These are our editorial judgements, not formal GRADE ratings.

3. How common is chronic pain?

The World Health Organization estimates that about 1.71 billion people live with musculoskeletal conditions, and that low back pain is the single leading cause of disability in 160 countries [1][2]. Global Burden of Disease analysis put low back pain at 619 million people in 2020 (uncertainty interval 554 to 694 million), projected to reach 843 million by 2050, with 38.8% of related years lived with disability attributed to occupational factors, smoking and high BMI [2]. That 38.8% is a modelled attributable share, not a guarantee that removing those factors would remove that much disability in practice.

One nuance matters for a paper about the modern environment: the same analysis found that age-standardised rates of low back pain fell by about 10.4% between 1990 and 2020, even as total case numbers grew [2]. The projected rise to 843 million largely reflects a growing and ageing population, not proof that modern life is making each person more likely to develop back pain. Burden statistics establish scale; they do not establish that modern life causes more pain.

In the UK, a 2016 systematic review pooled chronic pain prevalence at 43.5% of adults (95% confidence interval 38.4 to 48.6), rising from around 14% in 18 to 25 year olds to 62% in those over 75; between 10.4% and 14.3% live with pain that is moderately to severely disabling [3]. Estimates varied widely between the pooled studies, so this is best read as "roughly two in five adults" rather than a precise figure for today. In Great Britain in 2024/25, an estimated 511,000 workers had a work-related musculoskeletal disorder, accounting for an estimated 7.1 million working days lost, mostly affecting the back or the upper limb and neck [4].

Pain is common and becomes more common with age, and most low back pain is non-specific [32]. That already argues against any single-cause story.

Evidence strength: better established for scale and age gradient, with wide uncertainty on exact prevalence.

4. What role do genes play in chronic pain?

An Italian twin study modelling 750 pairs estimated broad-sense heritability at 0.36 for chronic pain occurrence and 0.31 for pain intensity [5]. Read carefully, this says less than it appears to. Heritability is a population statistic: it describes variation between people in one studied group under one set of circumstances, not the make-up of any individual's pain. It cannot tell us that 36% of a person's pain is genetic, or that the other 64% is environmental and changeable. These estimates also come from a single adult, predominantly Caucasian Italian cohort; they depend on model assumptions; and the genetic component was largely non-additive, which the authors themselves discuss cautiously.

What this study does establish frames the rest of this paper: genetic variation is relevant to chronic pain, environment and experience are relevant too, and the honest question is not which one wins but how they interact. A heritability estimate cannot rank nature against nurture, and this paper will not try to.

Evidence strength: suggestive. One large study, one population, one broad pain phenotype.

5. How are lifestyle and physical activity associated with pain?

Leisure-time physical activity is associated with an 11 to 16% lower relative risk of frequent or chronic low back pain across 36 prospective cohorts covering 158,475 people, though the authors urge caution: the data is observational [6]. That is a relative reduction, not percentage points off a person's absolute risk, and it concerns developing pain, not treating it. For people who already have chronic low back pain, a Cochrane review of 249 trials (24,486 adults) found exercise probably reduces pain compared with no treatment, usual care or placebo, with small average effects on function [7]. Preventing pain and treating it are different questions, and the evidence for each should not be borrowed to answer the other.

Reviews link adiposity with back, knee and foot pain, and smoking with low back pain, again observationally [8]. Diet and pain we treat as unreviewed here.

Evidence strength: suggestive for activity and adiposity (consistent observational signals, unproven causation); better established for exercise as treatment for existing low back pain, with modest effects.

6. What do sleep and stress research tell us about pain?

A 2024 meta-analysis of prospective cohorts (116,746 people) found sleep problems may raise later chronic musculoskeletal pain risk (odds ratio 1.39, 95% CI 1.21 to 1.59) [9]. The reverse direction is less certain: evidence that existing pain worsens later sleep was rated very uncertain over the longer term. So the two directions are not equally established, and an odds ratio of 1.39 means higher odds, not a 39% increase in absolute risk.

An umbrella review of 59 reviews (286 studies, 249,657 people) found depression, anxiety, distress and fear may increase the onset and persistence of musculoskeletal pain, while self-efficacy and better mental health may be protective [10]. A caveat worth knowing: the umbrella review's authors rated every included review as critically low confidence on the AMSTAR-2 tool, so these are informative signals, not settled facts. A separate meta-analysis supports the fear-avoidance model: catastrophising and fear of pain track with intensity, disability, anxiety and depression [11]. Adverse childhood experiences are associated with adult chronic pain in 85 studies covering 826,452 adults, with risk rising with the number of adversities (adjusted odds ratio 1.29 for one adversity, 1.95 for four or more) [12].

None of this means pain is "in the head". It means the system that processes pain is influenced by attention, fear, stress and history, which is precisely why guidelines include psychological approaches.

It also cuts both ways. Pain can change a person's environment as much as the environment shapes pain: someone in persistent pain may move less, sleep worse, work differently and see fewer people. A study that finds pain alongside inactivity or poor sleep cannot by itself say which came first. Any platform, including ours, that observes someone's behaviour must not confuse a useful signal with an established cause.

Evidence strength: suggestive. Consistent directions across large evidence bases, but mostly observational and rated low-certainty by the reviewers themselves.

7. Does sitting cause back pain?

Not in the simple way headlines suggest. A 2022 review of 16 longitudinal studies (100,002 people) found sedentary time was not associated with developing low back pain, though sitting three or more hours a day was associated with worse back-pain-related disability (odds ratio 1.24), not pain intensity [13]. A second review of ten prospective cohorts concluded sedentary behaviour probably does not contribute to new episodes of low back pain (pooled risk ratio 1.01) [14]. A broader 79-study review did find cross-sectional links between sitting and several pain conditions, but prospective evidence was insufficient or inconsistent [15]. Most underlying studies used self-reported sitting and were of fair quality, so this is not proof that prolonged sitting is harmless either. The fair reading: sitting duration alone is not an established cause of new back pain, and the modern suspicion that "sitting causes back pain" is not well supported in its strong form.

Evidence strength: better established that the strong claim is unsupported; the honest answer on harms of very prolonged sitting remains open.

8. How do work and social conditions relate to pain?

What shows firmer prospective signals than sitting itself is work organisation. Across 18 studies (19,572 people), workload, low job control, low decision authority and weak social support were significantly related to chronic low back pain, including in the prospective subset [16]. A systematic review of 50 prospective workplace studies found small but significant lagged associations between psychosocial stressors and later musculoskeletal problems (pooled odds ratios from 1.15 to 1.66) [17]. Shift work is associated with low back pain in a 40-study meta-analysis (odds ratio 1.31), driven by night shifts (odds ratio 1.49); rotating shifts were not significantly associated [18].

Interventions have a sobering record. A Cochrane review found workplace interventions to increase standing or walking did not clearly reduce musculoskeletal symptoms [19], and a separate Cochrane review found no clear benefit from single workstation adjustments or sit-stand desks for upper-limb pain [20]. A 2025 meta-analysis of 24 randomised ergonomics trials did find modest pain reduction overall (about a quarter of a point on a ten-point scale, and lower odds of reported lower-back pain) [21]. The fair summary is: ergonomics is worth doing properly, and it is not a universal cure.

Working from home during the pandemic shows how uncertain this territory is: a six-study rapid review found reported discomfort ranges so wide (neck pain in 20 to 77% of participants across studies, low back pain in 20 to 74%) that no single number means much [22]. In children and adolescents, one review of screen-related behaviours found prolonged mobile phone use associated with neck pain (odds ratio 1.36), with weaker and less consistent findings for screen time and sitting generally [23].

Evidence strength: suggestive for work organisation and night shifts; limited to mixed for ergonomic interventions; limited for home-working.

9. What do neighbourhoods and nature research tell us?

A large multilevel study of 22,892 older people in Japan associated good neighbourhood walkability (parks, pavements, food shops, fewer slopes and stairs) with lower prevalence of knee and low back pain [24]. Cross-sectional, one country, but suggestive. Housing studies are thin and setting-specific. On weather, a 2024 meta-analysis of 11 case-crossover studies (15,315 people) found no pooled association between humidity, air pressure, temperature or precipitation and low back or knee pain, whatever our knees tell us [25].

Nature exposure is an interesting signal with an important boundary. A 2026 systematic review and meta-analysis of 62 studies (4,439 participants across 21 countries) found lower self-reported pain with nature exposure, equivalent to roughly one point on a ten-point scale [26]. But nearly all of those studies concerned acute or procedural pain (colonoscopies, burn dressings, experimentally induced pain), not chronic musculoskeletal pain; effects roughly halved against well-matched comparators; heterogeneity was extreme; and over half the studies (33 of 62) were rated at high risk of bias. So: research on nature exposure offers evidence that some environmental stimuli can influence self-reported pain in particular settings. Whether these findings translate into meaningful, sustained improvements in chronic pain remains uncertain. The famous 1984 study of surgical patients with tree views versus brick-wall views found shorter stays and less potent analgesic use in the tree-view group; small, single-hospital and historical, but it opened the field [27]. Direct evidence that household lighting or noise changes musculoskeletal pain is much thinner.

Evidence strength: suggestive for acute and procedural pain; limited for chronic pain; not established for home environmental modification.

10. What do NICE, WHO and Cochrane recommend?

Guidance depends on the type of pain, so the sources do not all speak to the same person. For chronic primary pain in people aged 16 and over, NICE guideline NG193 recommends offering a supervised group exercise programme and considering acceptance and commitment therapy (ACT) or cognitive behavioural therapy (CBT) delivered by appropriately trained professionals, and recommends against offering biofeedback for that condition [28]. For chronic primary low back pain specifically, WHO issued a 2023 guideline on non-surgical management [29]. A Cochrane review of psychological therapies (75 studies, 9,401 people) found CBT probably reduces pain and distress by small amounts [30]. The 2018 Lancet low back pain series recommends a biopsychosocial approach, education and self-management first, with prudent use of medication, imaging and surgery [31][32].

Guidelines support several approaches to chronic pain, including appropriate physical activity, education and, in selected circumstances, psychological therapies. Recommendations depend on the type of pain and the individual's circumstances; no single approach is appropriate for everyone. The consensus is consistent, and it is modest. Anyone claiming a single dramatic fix is out of step with this literature.

Evidence strength: better established as guidance; the average effects behind it are real but modest.

11. Can pain be understood through repeated personal data?

Repeated real-time self-report (ecological momentary assessment) is an established method in pain research and suits pairing pain with context [33]. Wearable sensors for spine movement and digital health interventions for musculoskeletal pain have been reviewed, with mixed study quality [34]. In the literature we reviewed, studies that repeatedly measure a person's actual environment alongside their pain over long periods appear uncommon: research typically measures "environment" as a survey answer, a postcode or a job category, and typically tests one factor at a time. That is a gap in what we read, not proof that no such work exists; roughly 40 searches with abstract-level reading cannot measure the size of a research gap.

There is also a harder question beneath measurement. More data does not automatically produce better decisions. Suppose a system collects pain ratings, sleep, activity, work schedules, stress and surroundings. It still has to show that it can tell a contributing factor from a consequence, that acting on its observations improves pain, function or quality of life, that the benefit lasts, and that it does not generate false explanations that send people down unnecessary paths. Until those things are tested, contextual data is a research tool, not a validated solution.

Evidence strength: better established that the measurement methods exist; not established that environment-and-pain tracking improves outcomes.

12. What does the evidence not yet establish?

These are gaps identified in our initial evidence map. Some are established by the literature we reviewed, some are suggested but not comprehensively assessed, and some are simply questions we have not yet run the searches to answer.

13. What this research means for Recovapro

Our commercial thesis is that pain is personal, and that understanding a person's pain in the context of their life and environment may prove more useful than generic fixes. This review has tested that thesis against the evidence; here is where it leaves us, stated as plainly as we can.

What the evidence supports

The multifactorial, person-in-context model of pain. The value of self-management, education and describing pain by what it stops you doing. The existence of a real measurement question worth investigating. And the potential value of investigating environmental context, particularly in everyday living environments, which remains an open research question.

What the evidence does not establish

Current evidence does not support predicting an individual's pain from their surroundings, does not prove that changing a room changes chronic pain, and does not justify any product claiming to treat or cure. The research reviewed here links pain with several behavioural and psychosocial factors; it does not establish that a consumer gadget can identify the causes of an individual's pain. We hold ourselves to that boundary in everything we publish and build, and this paper is on the record as saying so.

What Recovapro does now, and what it is investigating

Three things should not be blurred together. This article is a review of other people's research about pain. Our current recovery products are judged on their own intended uses and evidence, which this paper does not provide. And the future platform is a research ambition, not a demonstrated capability. In practice we see three ambitions, each with its own evidence bar: helping people describe their pain clearly, which is useful without being diagnostic; helping people understand patterns in their own data, which requires distinguishing patterns from causes, and saying so; and helping people find appropriate support, which requires evidence that a recommendation is appropriate, safe and useful for the person receiving it.

The research questions ahead

The question this paper leaves us with is whether context adds real value beyond what people can already report about their own symptoms and circumstances. We intend to investigate that as a programme, not a philosophy, and to say in advance what would change our minds:

14. Conclusion

Pain is common, mostly non-specific, and shaped by nature and nurture in interaction rather than competition. Twin research estimates genetic factors account for roughly a third of the population variation in chronic pain occurrence, a statistic about differences between people in one studied population, not a recipe for dividing any one person's pain into nature and nurture shares. Research links several aspects of modern life and everyday environments with pain, although the strength and nature of those relationships vary considerably: sitting alone is a weaker villain than believed, while control, support, sleep, movement and stress carry firmer signals, and most of those signals are associations rather than proven causes. Several approaches have evidence of modest average benefit, but which is appropriate depends on the type of pain and the circumstances of the individual. The open frontier is measurement: following real people in their real environments over time, and testing honestly whether that knowledge improves anything that matters.

Pain is personal. Research increasingly recognises that biology, experience and environment interact; how best to use that understanding to guide individual support remains an open question, and it is the question we intend to keep working on.

15. References

[1] WHO musculoskeletal conditions fact sheet (figures from GBD 2019): https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions

[2] GBD 2021 low back pain analysis, Lancet Rheumatology 2023: https://pubmed.ncbi.nlm.nih.gov/37273833/

[3] Fayaz et al., UK chronic pain prevalence, BMJ Open 2016: https://bmjopen.bmj.com/content/6/6/e010364

[4] HSE work-related MSD statistics 2024/25: https://www.hse.gov.uk/statistics/assets/docs/msd.pdf

[5] Italian twin study of chronic pain heritability, Medicina 2022: https://pmc.ncbi.nlm.nih.gov/articles/PMC9697129/

[6] Shiri and Falah-Hassani, leisure-time physical activity and low back pain, BJSM 2017: https://bjsm.bmj.com/content/51/19/1410

[7] Cochrane, exercise for chronic low back pain 2021: https://www.cochrane.org/evidence/CD009790_exercise-treatment-chronic-low-back-pain

[8] Adiposity and back and lower limb pain, PLOS One 2021: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256720

[9] Sleep and musculoskeletal pain meta-analysis, PAIN 2024: https://pubmed.ncbi.nlm.nih.gov/38809241/

[10] Psychological factors umbrella review, JPain 2020: https://pubmed.ncbi.nlm.nih.gov/32379072/

[11] Fear-avoidance model meta-analysis: https://pmc.ncbi.nlm.nih.gov/articles/PMC9541898/

[12] Adverse childhood experiences and chronic pain meta-analysis: https://pubmed.ncbi.nlm.nih.gov/38111090/

[13] Sedentary behaviour and low back pain, 16 longitudinal studies 2022: https://pubmed.ncbi.nlm.nih.gov/35391924/

[14] Sedentary behaviour and new episodes of low back pain, prospective review 2022: https://pubmed.ncbi.nlm.nih.gov/35598285/

[15] Sedentary behaviour and musculoskeletal pain, 79-study review: https://link.springer.com/article/10.1186/s12966-021-01191-y

[16] Psychosocial areas of worklife and chronic low back pain, BMC Musculoskeletal Disorders 2019: https://link.springer.com/article/10.1186/s12891-019-2826-3

[17] Lang et al., psychosocial work stressors and musculoskeletal problems, 50 prospective studies 2012: https://pubmed.ncbi.nlm.nih.gov/22682663/

[18] Shift work and low back pain meta-analysis: https://pmc.ncbi.nlm.nih.gov/articles/PMC9858896/

[19] Cochrane, workplace interventions for standing or walking: https://www.cochrane.org/evidence/CD012487_workplace-interventions-increasing-standing-or-walking-de

[20] Cochrane, ergonomic interventions for upper limb and neck MSDs: https://europepmc.org/article/MED/30350850

[21] Ergonomic interventions randomised trials meta-analysis 2025: https://www.mdpi.com/2077-0383/14/9/3034

[22] Work from home and musculoskeletal pain rapid review: https://pmc.ncbi.nlm.nih.gov/articles/PMC9731643/

[23] Sedentary behaviour and neck pain in children and adolescents: https://pmc.ncbi.nlm.nih.gov/articles/PMC9808908/

[24] Neighbourhood walkability and pain in older people, Japan (JAGES): https://www.mdpi.com/1660-4601/16/23/4598

[25] Weather and musculoskeletal pain meta-analysis 2024: https://pubmed.ncbi.nlm.nih.gov/38340613/

[26] Nature exposure and pain meta-analysis, Nature Mental Health 2026: https://www.nature.com/articles/s44220-025-00569-2

[27] Ulrich 1984, view through a window: https://europepmc.org/article/MED/6143402

[28] NICE NG193, chronic pain (primary and secondary) in over 16s: https://www.ncbi.nlm.nih.gov/books/NBK569960/

[29] WHO 2023 guideline, non-surgical management of chronic primary low back pain: https://www.who.int/publications/i/item/9789240081789

[30] Cochrane, psychological therapies for chronic pain: https://www.cochrane.org/evidence/CD007407_what-are-benefits-and-risks-psychological-therapies-adult

[31] Hartvigsen et al., Lancet low back pain series 2018: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30480-X/abstract

[32] Foster et al., Lancet low back pain series 2018: https://www.thelancet.com/article/S0140-6736(18)30489-6/fulltext

[33] Ecological momentary assessment in pain research: https://pmc.ncbi.nlm.nih.gov/articles/PMC7737856/

[34] Wearable sensors for spine movement review: https://pmc.ncbi.nlm.nih.gov/articles/PMC5700811/

About this review

Prepared by The Recovapro Research Team. An earlier draft received a critical editorial review (30 October 2026); the corrections it required are applied in this version, and the corrected draft was re-reviewed the same way on 1 November 2026, scoring 8.2/10 with targeted corrections that have since been applied. These were editorial critiques, not independent scientific peer review; no external scientific review has yet taken place. Every cited figure was checked against the named source between 30 October and 1 November 2026, in full text where openly available and otherwise at abstract, summary or guideline-page level; full papers were not formally appraised. Published: 1 November 2026. Editorial responsibility: The Recovapro Research Team. Review date: we will revisit this article as the evidence changes.

Conflicts of interest: Recovapro sells recovery products and is developing pain-related technology. This article does not evaluate or establish the effectiveness of any Recovapro product or technology.

Corrections: if you spot an error, tell us and we will correct the record.

Recovapro is a British recovery-technology company. This article explores published research on pain and the interaction between biological, behavioural and environmental factors. It is educational, not medical advice, and describes a narrative evidence review, not a systematic review. If pain is new, changing or worrying, speak to a GP.

x